FDA
approval
· 2023-05-08
FDA Approved: ATOMOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
The FDA approved Camber Pharmaceuticals’ supplemental application for atomoxetine, enabling a generic product. Atomoxetine is used to treat attention deficit hy…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ATOMOXETINE (ATOMOXETINE)